The new and promising therapy "antigenic"
The therapy is based on the formation of triple helices of DNA and light energy to silence gene activity
The antigenic therapy is an innovative treatment strategy which provides for the use of DNA-based drugs to precisely locate the light energy on a target gene, thus turning off its activity.
A recently published review of Oligonucleotides, a peer-reviewed journal published by Mary Ann Liebert, Inc. of New Rochelle (New York), analyzes the opportunities and challenges for the clinical application of this new approach through modulation of DNA photo-activation. The review can be viewed for free at segnente link (Site-Specific DNA Photocleavage by Oligonucleotide Conjugates and Photomodulation)
Netanel Kolevzon and Eylon Yavin, of The Hebrew University of Jerusalem (Israel), in their article describing the mechanism that undergirds antigen and development of drugs based on TFO (which stands for Triple Forming Oligonucleotide), capable of inhibiting the expression gene in a highly focused and selective.
The TFO are in fact oligonucleotides (synthetic) capable of forming a triple helix, introducing in the major groove of the double helix and creating type Hoogsteen hydrogen bonds with the purine of the pairs of Watson-Crick base ¹ : Unlike antisense therapies already existing, that target RNA, therapy has therefore as antigenic targets directly on a DNA sequence.
By attaching a photoreactive agent TFO oligonucleotide, and providing light energy to the attachment site on the genome, the drug (light sensitive) is activated and triggers a cleavage or cross-linking of DNA, that damage to the genome, photo- induced and site-specific, will result in gene silencing.
"Many obstacles lie ahead before this strategy can be applied clinically," the authors warn. In any case, if the therapy will prove antigenic actually valid "many diseases that are currently incurable or otherwise treatable with poor results, could be potential applications of this kind of approach," they conclude.
"This is a clever and potentially very effective approach for regulating targeted gene expression," says John Rossi, PhD, co-editor of Oligonucleotides and Professor at the Department of Molecular Biology, Beckman Research Institute (California)








Latest Comments
◊ daisy @ OCD: a study in 2007 revealed a possible hereditary factor :
◊ daisy @ OCD: a study in 2007 revealed a possible hereditary factor :
◊ Colaiacovo Moreno @ The bacteria have an acquired immune system :
◊ paul @ Uncovered genes for synthesis of codeine and morphine in the opium poppy :
◊ Pedrito @ Uncovered genes for synthesis of codeine and morphine in the opium poppy :